您好,欢迎访问湖南甲骨文生物医药有限公司官网!

当前位置: 首页 > 主营项目 > 试剂盒 > Gateway® Vector Conversion System with One Shot® ccdB Survival Cells

  • Gateway® Vector Conversion System with One Shot® ccdB Survival Cells

blob.png


产品概述

描述

The Gateway® Vector Conversion System is designed to convert any vector into a Gateway® destination vector using restriction endonucleases and ligase. A Gateway® cassette containingattR recombination sites flanking a ccdB gene (1) and a chloramphenicol-resistance gene are blunt-end cloned into the multiple cloning site of any vector. ccdB Survival 2 competent cells allow propagation of the Gateway® vectors containing the ccdB gene. The Gateway® Vector Conversion System offers: 
• Conversion of any expression vector into a Gateway® destination vector
• Three cassettes to construct a destination vector in the correct reading frame. Each cassette has a unique restriction site to easily distinguish the cassettes and screen for the correct orientation.

规格

Product Size:1 kit
Cloning Method:Gateway®
Bacterial or Yeast Strain:ccdB Survival™ 2
Antibiotic Resistance (Bacterial):Chloramphenicol (CmR)

内容及储存

The Gateway® Vector Conversion System contains Gateway® Reading Frame Cassettes A, B, and C.1, pENTR™-gus positive control, and One Shot® ccdB Survival Cells. Store DNA at -20°C and competent cells at -80°C.

Figures

blob.png


手册

化学品安全技术说明书(MSDS)

















引用及参考文献

Royer Y, Menu C, Liu X, Constantinescu SN, 
DNA Cell Biol (2004) 23:355-365
Product usage: Customer converted several bicistronic retroviral vectors containing a variety of different genes downstream of an IRES (GFP, CD2, or CD4) as reporters, to Gateway destination vectors in order to facilitate high-throughput cloning of any number of genes. They transferred EpoR via

Su LT, Agapito MA, Li M, T N Simonson W, Huttenlocher A, Habas R, Yue L, Runnels LW, 
J Biol Chem 2006 0(0):-
Product usage: The Flp-in T-Rex system was used in conjunction with Flp-in T-Rex 293 cells for regulated, isogenic expression of the ion channel-kinase, TRPM7 and TRPM7 kinase mutants as well as shRNAs targeted to TRPM7. This helped in testing the function of the kinase domain and in determinin

Dubin MJ, Bowler C, Benvenuto G, 
Plant Methods (2008) 4:3-3
Product usage: An alternative Gateway-based strategy is reported that has been developed to create N- or C-terminally tagged protein overexpression constructs that lack attB-derived linker amino acids between the protein of interest and the tag. The attB sequences are avoided because the tag is


  选择国家/语言

Global - English China - 中文